About this trial
The objective of this study is to develop a Decision Aid for Lung Cancer Molecular Testing (DA\_LCMT) and to facilitate shared-decision making in patients who were diagnosed with lung adenocarcinoma by intraoperative frozen pathology about whether to conduct the molecular testing.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
Non-random purposive sampling will be used to select key respondents to participate in in-depth interviews. Snowball sampling, where potential participants are asked to identify others who may be willing to participate, as well as convenience sampling, will be utilized. For patients, we will aim for diversity regarding age, sex, education level, and annual household income. For other stakeholders (including thoracic surgeons, nurses, psychoanalysts, hospital administrators, molecular testing company staff, and insurance company staff), the representativeness in region, seniority, position, and attitude toward both molecular testing and SDM will be considered.
Trial design
Case-crossover
Prospective
Treatments tested in this trial
Qualitative interviews
Other interventionWe will conduct semi-structured interviews with target patients, patients' representatives and other stakeholders to assess their decisional needs. The cognitive debriefing interview will start afterwards, and participants will answer probing questions asked by interviewers about DA\_LCMT 1.0. Then the field testing interviews will conducted one-on-one structured interviews.
Treatment groups
Trial outcomes
Primary outcomes
The DA_LCMT 3.0
The DA\_LCMT 3.0 is the final version in this study which must conform to the International Patient Decision Aid Standards (IPDAS)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Sichuan Cancer Hospital and Research Institute
Lead sponsor
Jiangyou People's Hospital
Collaborator
Wu Jieping Medical Foundation
Collaborator
Chongqing Medical University
Collaborator
The Third People's Hospital of Chengdu
Collaborator